Abstract
Surgery is the single most effective therapy for patients with solid tumors. However, up to half of the patients who receive surgical resection will relapse from their cancer. Despite the significant benefit from surgery, there is a growing body of evidence that suggests that surgery may also contribute to tumor recurrence. The evidence supporting this claim can be divided into immunologic and non-immunologic mechanisms. The non-immunologic mechanisms associated with surgery include direct seeding through tissue manipulation, pressure activation of malignant cells, the release of angiogenic factors, and an increase in circulating growth factors. Surgery also has dramatic implications for the immune system; these include the suppression of cell-mediated immunity, the activation of the neuroendocrine response, and anesthesia related immunosuppression. The factors associated with post-surgical tumor recurrence are complex; nevertheless, a better understanding of these mechanisms provides an opportunity to develop therapeutic interventions that can lower the recurrence rate in patients with solid tumors.
Keywords: Cell mediated immunity, Immunosuppression, Mechanical seeding, Tumor recurrence
Current Cancer Therapy Reviews
Title:“Letting the Air In” Can Set the Stage for Tumor Recurrences
Volume: 8 Issue: 4
Author(s): Benjamin A. Laguna, Zachary C. G. Tucker, Horace DeLisser and Sunil Singhal
Affiliation:
Keywords: Cell mediated immunity, Immunosuppression, Mechanical seeding, Tumor recurrence
Abstract: Surgery is the single most effective therapy for patients with solid tumors. However, up to half of the patients who receive surgical resection will relapse from their cancer. Despite the significant benefit from surgery, there is a growing body of evidence that suggests that surgery may also contribute to tumor recurrence. The evidence supporting this claim can be divided into immunologic and non-immunologic mechanisms. The non-immunologic mechanisms associated with surgery include direct seeding through tissue manipulation, pressure activation of malignant cells, the release of angiogenic factors, and an increase in circulating growth factors. Surgery also has dramatic implications for the immune system; these include the suppression of cell-mediated immunity, the activation of the neuroendocrine response, and anesthesia related immunosuppression. The factors associated with post-surgical tumor recurrence are complex; nevertheless, a better understanding of these mechanisms provides an opportunity to develop therapeutic interventions that can lower the recurrence rate in patients with solid tumors.
Export Options
About this article
Cite this article as:
A. Laguna Benjamin, C. G. Tucker Zachary, DeLisser Horace and Singhal Sunil, “Letting the Air In” Can Set the Stage for Tumor Recurrences, Current Cancer Therapy Reviews 2012; 8 (4) . https://dx.doi.org/10.2174/1573394711208040293
DOI https://dx.doi.org/10.2174/1573394711208040293 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Predicting Drug Metabolism Induction In Silico
Current Topics in Medicinal Chemistry Gender Disparity in Pediatric Diseases
Current Molecular Medicine Potential Strategies for Minimizing Mechanism-Based Inhibition of Cytochrome P450 3A4
Current Pharmaceutical Design Immune Responses to Fungal Infections and Therapeutic Implications
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Comparison of Rat and Human Intestinal and Hepatic Glucuronidation of Enterolactone Derived from Flaxseed Lignans
The Natural Products Journal MMPs in Ovarian Cancer as Therapeutic Targets
Anti-Cancer Agents in Medicinal Chemistry Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases
Current Gene Therapy Safety Considerations Associated with Development and Clinical Application of Lentiviral Vector Systems for Gene Transfer
Current Genomics Paraneoplastic Pemphigus: Autoimmune-Cancer Nexus in the Skin
Anti-Cancer Agents in Medicinal Chemistry Disruption of Circadian Rhythms and Sleep in Critical Illness: Potential Implications for Angiogenesis After Myocardial Infarction. A Review
Current Pharmaceutical Design Potential Application of Biliverdin Reductase and its Fragments to Modulate insulin/IGF-1/MAPK/PI3-K Signaling Pathways in Therapeutic Settings
Current Drug Targets Management of Vaginal Cancer
Reviews on Recent Clinical Trials Probiotic Lactobacilli: A New Perspective for the Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Design Anti-IL-1 β Therapies
Recent Patents on DNA & Gene Sequences Central and Peripheral Pain Generators in Women with Chronic Pelvic Pain: Patient Centered Assessment and Treatment
Current Rheumatology Reviews Recent Advances in Pharmacological Interventions of Chronic Prostatitis/ Chronic Pelvic Pain Syndrome
Current Pharmaceutical Design Hepatobiliary Diseases and Insulin Resistance
Current Medicinal Chemistry Realizing the Potential of Health-Promoting Rosehips from Dogroses (Rosa sect. Caninae)
Current Bioactive Compounds Multicenter Randomized Controlled Trial for the Treatment of Ulcerative Colitis with a Leukocytapheresis Column
Current Pharmaceutical Design Preclinical Investigation of Radiopharmaceuticals: An Accurate and Multidisciplinary Approach
Current Radiopharmaceuticals